Targeting DESI2 as a Novel Therapeutic Strategy for JAK2‐Mutant Leukemias
Abstract
Research context
OpenAlex topics: Cytokine Signaling Pathways and Interactions · Ubiquitin and proteasome pathways · Immunodeficiency and Autoimmune Disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Hematology Tongji Hospital Frontier Science Center for Stem Cell Research Shanghai Key Laboratory of Signaling and Disease Research School of Life Sciences and Technology Tongji University Shanghai 200092 P. R. China
Department of Radiation and Medical Oncology Medical Research Institute Frontier Science Center of Immunology and Metabolism Hubei Key Laboratory of Tumor Biological Behavior Zhongnan Hospital of Wuhan University Wuhan University Wuhan 430071 P. R. China
Key Lab of Chemical Biology School of Pharmaceutical Sciences Cheeloo College of Medicine Shandong University Jinan Shandong 250012 P. R. China
State Key Laboratory of Experimental Hematology National Clinical Research Center for Blood Diseases Haihe Laboratory of Cell Ecosystem Tianjin & CAMS Key Laboratory of Gene Therapy for Blood Diseases Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin 300020 P. R. China
Anhui Province Key Laboratory of Medical Physics and Technology Institute of Health and Medical Technology Hefei Institutes of Physical Science Chinese Academy of Sciences Hefei 230031 P. R. China
Lingang Laboratory Shanghai 200031 P. R. China
Interdisciplinary Research Center on Biology and Chemistry Shanghai Institute of Organic Chemistry Chinese Academy of Sciences Shanghai 201210 P. R. China
Institute of Translational Medicine Medical College Yangzhou University Yangzhou 225001 P. R. China
Funding
National Natural Science Foundation of China · National Key Research and Development Program of China · Fundamental Research Funds for the Central Universities · China Postdoctoral Science Foundation